Long-term follow-up of patients with aplastic anemia and refractory anemia responding to combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin

International Journal of Hematology

Volumn 76, Issue 3, 2002, Pages 244-250

  Matsuda, Akira ^a   Kishimoto, Kuniya ^a   Yoshida, Katsuhiko ^a   Yagasaki, Fumiharu ^a   Ito, Yoshihiro ^a   Sakata, Tohru ^a   Kawai, Nobutaka ^a   Ino, Hirohide ^a   Hirashima, Kunitake ^a   Bessho, Masami ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Aplastic anemia; Erythropoietin; Granulocyte colony stimulating factor; Refractory anemia

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE LEUKEMIA; APLASTIC ANEMIA; ARTICLE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; LONG TERM CARE; QUALITY OF LIFE; REFRACTORY ANEMIA; SURVIVAL TIME; ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BLOOD TRANSFUSION; FEMALE; MALE; MIDDLE AGED; MYELOID LEUKEMIA; PATHOLOGY; SURVIVAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ANEMIA, REFRACTORY; BLOOD TRANSFUSION; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 17144461097     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982794     Document Type: Article

References (20)

1. Negrin RS, Haeuber DH, Nagler A, et al. Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood. 1990;76:36-43.
2. Yoshida Y, Hirashima K, Asano S, Takaku F. A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes. Br J Haematol. 1991;78:378-384.
3. Bessho M, Jinnai I, Matsuda A, Saito M, Hirashima K. Improvement of anaemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anaemia. Int J Cell Cloning. 1990;8:445-458.
4. Hellström E, Birgegård G, Lockner D, Helmers C, Öst Å, Wide L. Treatment of myelodysplastic syndromes with recombinant human erythropoietin. Eur J Haematol. 1991;47:355-360.
5. Rose EH, Abels RI, Nelson RA, McCullough DM, Lessin L. The use of r-HUEpo in the treatment of anaemia related to myelodysplasia (MDS). Br J Haematol. 1995;89:831-837.
6. Hellström-Lindberg E. Efficacy of erythropoietin in the myelodysplastic syndromes: an analysis of 205 patients in 17 studies. Br J Haematol. 1995;89:67-71.
7. Negrin RS, Stein R, Doherty K, et al. Treatment of the anaemia of myelodysplastic syndromes using human granulocyte-CSF in combination with erythropoietin. Blood. 1993;82:737-743.
8. Hellström-Lindberg E, Birgegård G, Carlsson M, et al. A combination of granulocyte-colony-stimulating factor and erythropoietin may synergistically improve the anaemia in patients with myelodysplastic syndromes. Leuk Lymphoma. 1993;11:221-228.
9. Frickhofen N, Kaltwasser JP, Schrezenmeier H, et al. Treatment of aplastic anemia with antithymocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med. 1991;324:1297-1304.
10. Rosenfeld SE, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 1995;85:3058-3065.
11. Bacigalupo A, Bruno B, Saracco P, et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. Blood. 2000;95:1931-1934.
12. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol. 1988;69:413-418.
13. Socie G, Amar MH, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med. 1993;329:1152-1157.
14. Ohara A, Kojima S, Hamajima N, et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood. 1997;90:1009-1013.
15. Bessho M, Jinnai I, Hirashima K, et al. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia. Stem Cells. 1994;12:604-615.
16. Bessho M, Toyoda A, Itoh Y, et al. Trilineage recover by combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEpo) in severe aplastic anemia. Br J Haematol. 1992;80:410-411.
17. Kojima S, Nakao S, Tomonaga M, et al. Consensus Conference on the Treatment of Aplastic Anemia. Int J Hematol. 2000;72:118-123.
18. Marsh J, Schrezenmeier H, Marin P, et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood. 1999;93:2191-2195.
19. Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. J Clin Oncol. 1998;16:3412-3425.
20. Kaito K, Kobayashi M, Katayama T, et al. Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. Br J Haematol. 1998;103:297-303.